Mater Clinical Trials

Mater conducts clinical trials in a range of therapeutic areas including Cancer, Neurology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers’ and Babies Health.  Clinical trials are an essential component of healthcare.  They provide the evidence to evaluate the safety and efficacy of new treatments and diagnostics, and provide alternative treatment options for patients with unmet needs. 

Mater currently has over 200 active clinical trials. These trials include commercial pharmaceutical and medical device studies, as well as collaborative group studies and investigator-initiated studies, led by Mater’s researchers and collaborators at The University of Queensland and other leading Australian and international medical research institutions.

Without volunteers, clinical trials are not possible. If you are interested in being involved – you may be a patient with a new diagnosis, a patient with a long term diagnosis or a healthy volunteer – view available trials below or contact the Mater Clinical Trials team.

The Medical Oncology Clinical Research team, based within the Mater Cancer Care Centre, currently has 22 actively recruiting trials.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
Medicinal cannabis for advanced cancer patients – driving implications
Trial Status:
Recruiting
|
Contact:
Mater Palliative and Supportive Care Research
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease
Trial Status:
Active, not recruiting
|
Contact:
Mothers and Babies Research Team
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
Trial Status:
Recruiting
|
Contact:
RIO Clinical Trials Unit
Using Electrical Impedance Tomography to Evaluate the Effect of Positioning in Neonates with Congenital Diaphragmatic Hernias
Trial Status:
Recruiting
|
Contact:
Dr Judith Hough
A Phase III, double-blind, placebo-controlled, Randomised, Multicentre, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizumab in Patients With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Definitive, Platinum-Based Concurrent Chemoradiation Therapy.
Trial Status:
Recruiting
|
Contact:
Stevie Anderson
Study of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Status:
Recruiting
|
Contact:
Sharyn Grossman
This trial is for people with gynaecological cancers whose tumours are potentially treatable with endocrine treatment.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
This study is trialing a novel drug, called JNT-517, which works by increasing excretion of phenylalanine in the urine to reduce circulating levels in the blood.
Trial Status:
Active, not recruiting
|
Contact:
Yvonne Gautam
Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With Chronic obstructive pulmonary disease (COPD) and Chronic Bronchitis
Trial Status:
Recruiting
|
Contact:
RIO Clinical Trials Unit
Displaying results 31-40 (of 61)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7  >  >|